1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、官网网址（微信公众号信息）：

https://www.keaipublishing.com/en/journals/molecular-and-digital-medicine/

4、投稿网址：

https://www.editorialmanager.com/mdmed/default2.aspx

5、官网邮箱：mdmedicine@sdu.edu.cn

6、出刊日期：连续出版。

7、官方微信公众号：MD-Medicine

8、官网信息：2028年12月31日前免收文章出版费

2026年6月16日星期二

Guide for Authors

【官网信息】

About the journal

Journal announcements

Announcing Molecular and Digital Medicine: A New Journal Fusing Life Sciences, Engineering, and Digital Innovation

We

are proud to announce the launch of Molecular and Digital Medicine, a

pioneering, multidisciplinary open-access journal dedicated to

publishing high-impact research at the convergence of molecular

bioscience, biomedical engineering, and digital health technologies.

This

new journal addresses a critical need for a unified platform that

bridges the gap between groundbreaking discoveries in the lab and their

translation into intelligent, data-driven clinical applications.

Molecular and Digital Medicine will provide a forum for the rapid

dissemination of peer-reviewed articles that explore how the integration

of molecular insights, advanced engineering, and computational power is

revolutionizing the future of personalized medicine, diagnostics, and

therapeutics.

Scope and Mission:

The

journal's scope encompasses the full spectrum of translational

research, from fundamental molecular mechanisms to clinical

implementation. Key areas of interest include:

Molecular & Nanoscale Medicine: Genomics, biomarkers, nanomedicine, targeted drug delivery, and regenerative medicine.

Digital Health Technologies: AI/ML in healthcare, wearable devices, digital therapeutics, and health informatics.

Converging

Technologies: The integration of molecular data with digital platforms,

AI-driven analysis of omics data, and the development of "smart"

diagnostic and therapeutic systems enabled by biomaterials and

engineering.

"Molecular

and Digital Medicine will be essential reading for molecular

biologists, clinicians, data scientists, biomedical engineers, and all

researchers working to create the next generation of precision

healthcare solutions," said the Founding Editor-in-Chief. "Our goal is

to accelerate innovation by fostering collaboration across these

traditionally siloed fields."

Molecular and Digital Medicine is now inviting submissions and applications for Editorial Board positions.

For more information, visit: https://www.keaipublishing.com/en/journals/molecular-and-digital-medicine/

Aims and scope

Molecular

and Digital Medicine is a pioneering, multidisciplinary, open-access

journal dedicated to advancing research at the dynamic convergence of

molecular biology, digital technologies, and biomedical engineering. The

journal aims to publish high-quality, peer-reviewed research that

explores the innovative integration of molecular science with digital

health tools and engineering solutions, with the ultimate goal of

revolutionizing personalized medicine, diagnostics, and therapeutic

interventions.

Our

scope encompasses the full spectrum of research at this pivotal

intersection. This includes foundational and applied research in

Molecular and Nanoscale Medicine, such as molecular diagnostics,

biomarkers, omics sciences, precision medicine, nanomedicine, gene

editing, and biomaterials. A core focus is also on Digital Health

Technologies, including artificial intelligence (AI) and machine

learning, digital therapeutics, wearable devices, biosensors, and health

informatics.

A

distinctive priority is the Integration and Convergence of these

fields, covering areas like digital biomarkers, AI-driven multi-omics

analysis, engineered diagnostic devices, smart theranostic platforms,

and digital tools for clinical trials. The journal strongly emphasizes

Clinical Applications and Translational Medicine, welcoming work that

bridges these discoveries into clinical practice, develops personalized

strategies and devices, and addresses the associated ethical,

regulatory, and security challenges.

Molecular

and Digital Medicine seeks to foster essential collaborations across

disciplines, including molecular biology, bioinformatics, clinical

medicine, biomedical engineering, and digital health, to catalyse the

development of innovative, end-to-end solutions that improve patient

care, healthcare delivery, and global health outcomes.

Editorial Board

Article types

Molecular

and Digital Medicine publishes a wide range of content, showcasing the

latest advancements at the intersection of molecular biology, digital

health, biomedical engineering, and nanomedicine:

Article type

Description

Original Research

Substantive reports of novel, data-driven research that presents a significant advance in the field.

Review Articles

Comprehensive,

authoritative, and narrative reviews of current literature and trends

in a specific area. (Invitation encouraged, but not required)

Systematic Reviews

Rigorous,

protocol-driven reviews that identify, evaluate, and synthesize all

relevant studies to answer a specific research question.

Brief Communications

Significant, high-impact research that merits rapid communication, often of a preliminary nature.

Clinical Reports

Detailed

analyses of a single or small series of unique patient cases that

provide novel insights into disease mechanisms, diagnosis, or treatment.

This category also includes early clinical reports on the application

of novel technologies (e.g., a new biosensor, digital therapeutic, or

biomaterial implant). Must include patient consent and ethical approval.

Methodologies

Articles

describing new or significantly improved experimental methods,

computational tools, software, or engineering protocols relevant to the

journal's scope.

Perspectives & Opinions

Articles presenting a personal viewpoint, a speculative hypothesis, or a commentary on future directions in the field.

Correspondence

Short letters commenting on a recent article published in the journal, fostering scientific discussion.

Commentary

Focused

perspectives on emerging topics, methodologic advances, or key findings

in molecular and digital medicine (not limited to commenting on

published articles).

Meeting Reports

Summaries of key findings, trends, and discussions from major scientific conferences and symposia.

News & Views

Concise updates on recent breakthroughs, regulatory news, major funding initiatives, or significant events.

Data Notes

Short descriptions of scientifically valuable datasets deposited in public repositories, enhancing data reuse and discovery.

Editorial

Editorials

are authoritative, editorially curated articles offering expert

perspectives on timely, relevant topics in molecular and digital

medicine. They may address emerging trends, key advancements, or

impactful developments in the field, or introduce thematic

issues/landmark content. Balanced, concise, and grounded in current

evidence, editorials should provide actionable insights for clinical

practice, research, or translation.

Letter

Letters

are concise, timely communications that provide critical commentary on

recently published articles in the journal, present novel preliminary

findings, or offer insights on emerging issues in clinical practice,

health research, or medical policy.

Consensus and Guideline

Consensuses

and Guidelinesare official recommendations from professional

organizations on issues related to clinical practice and health care

delivery. CD is flexible with length, reference, and other format

requirements given the variability in the format of guidelines developed

by different organizations. A concise table or concise graphic

summarizing the recommendations and other key points is desirable.

Guidelines that meet standards (http://www.equator-network.org/) will

fare more favorably than those that do not.

Guideline Snapshot

Guideline

Snapshots are concise, accessible summaries of existing, high-quality

clinical or research guidelines. They distill core recommendations, key

applicable scenarios, and critical evidence highlights from full

guidelines (e.g., those meeting EQUATOR Network standards or issued by

authoritative professional organizations) without replicating detailed

methodological processes or extensive discussions.

Detailed Article Types

Molecular

and Digital Medicine welcomes the following types of submissions. All

manuscripts must adhere to the highest standards of ethical and

scientific rigor and will undergo rigorous peer review.

1. Original Research

Description:

Full-length, substantial reports of original basic, translational,

clinical, or engineering research that presents a significant advance in

the field. The work should be hypothesis-driven and provide novel

insights, data, or methodologies.

Abstract:

Structured to include the elements of Background, Methods, Results, and

Conclusion, but without subheadings. No more than 250 words.

Main

Text: Typically 3,000-5,000 words (excluding references and figure

legends). Should follow the standard IMRaD structure: Introduction,

Methods, Results, Discussion.

References: No specific limit, but should be relevant and appropriate.

Figures/Tables: Typically 4-8 items in total.

2. Review Articles

Description:

Comprehensive, authoritative, and narrative surveys of a specific topic

within the journal's scope. They should provide critical analysis,

synthesize existing literature, and discuss future directions, rather

than simply summarizing publications. Authors are strongly encouraged to

contact the Editors prior to submission to propose a topic.

Abstract: Unstructured, no more than 250 words.

Main

Text: Typically 5,000-8,000 words. Should include an Introduction,

thematic sections, and a Conclusion/Future Perspectives section.

References: Extensive and representative of the field.

Figures/Tables: Encouraged to illustrate key concepts (e.g., schematic diagrams, comparative tables).

......

更多详见：

https://www.keaipublishing.com/en/journals/molecular-and-digital-medicine/guide-for-authors